Innovage/$INNV
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Innovage
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. It manages its business as one reportable segment, PACE.
- Ticker
- $INNV
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 2,500
- Headquarters
- Denver, United States
- Website
- www.innovage.com
Innovage Metrics
BasicAdvanced
$1.2B
149.38
$0.06
0.19
-
Price and volume
Market cap
$1.2B
Beta
0.19
52-week high
$12.64
52-week low
$4.17
Average daily volume
658K
Financial strength
Current ratio
1.163
Quick ratio
0.984
Long term debt to equity
0.245
Total debt to equity
0.29
Interest coverage (TTM)
3.48%
Profitability
EBITDA (TTM)
39.244
Gross margin (TTM)
68.41%
Net profit margin (TTM)
0.88%
Operating margin (TTM)
1.72%
Effective tax rate (TTM)
-1.12%
Revenue per employee (TTM)
$410,000
Management effectiveness
Return on assets (TTM)
2.04%
Return on equity (TTM)
4.43%
Valuation
Price to earnings (TTM)
149.381
Price to revenue (TTM)
1.213
Price to book
4.86
Price to tangible book (TTM)
11.25
Price to free cash flow (TTM)
16.188
Free cash flow yield (TTM)
6.18%
Free cash flow per share (TTM)
0.562
Growth
Revenue change (TTM)
15.11%
Earnings per share change (TTM)
-147.43%
3-year revenue growth (CAGR)
13.34%
3-year earnings per share growth (CAGR)
-39.88%
What the Analysts think about Innovage
Analyst ratings (Buy, Hold, Sell) for Innovage stock.
Analyst projections of the future price of Innovage stock.
Bulls say / Bears say
In fiscal Q1 2027, revenue rose 12.1%, participant census grew 6.7% and net income increased to $20.9 million from $7.7 million a year earlier, showing continued growth alongside improved profitability. (InnovAge)
Operating performance improved sharply in fiscal 2026: adjusted EBITDA rose to $94.6 million from $34.5 million, while centre-level contribution margin increased to 23% of revenue from 18%. (InnovAge)
InnovAge’s filing estimates that about 2.3 million Americans may be eligible for PACE, while only around 95,000 were enrolled in June 2026, suggesting substantial room for the model to grow if the company can execute. (SEC)
Federal changes to Medicaid funding and eligibility could reduce government support and make it harder for some seniors to remain eligible; InnovAge warns these changes could adversely affect its business and finances. (SEC)
The company faces unresolved government investigations: it received supplemental Justice Department demands in December 2025 and says discussions over potential resolutions are ongoing, with no assurance that any eventual loss will stay within its estimate. (SEC)
California and Colorado account for about 70% of census, and their Medicaid rate-setting processes were still pending amid state budget pressure; weaker final rates could put pressure on revenue and margins. (Exa)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2026.
Innovage Financial Performance
Revenues and expenses
Innovage Earnings Performance
Company profitability
Upcoming events
No upcoming events
Innovage News
AllArticlesVideos
Funds containing Innovage
Fund name | Fund size | $INNV weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.01% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.